Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300197
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,215
Award facts
- Contract value 100% obligated
- $5,215.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, was awarded a Firm Fixed Price BPA (Blanket Purchase Agreement) call valued at $5,215.20 on May 24, 2012, for the provision of drugs and biologicals. The contract, which was funded by the Office of the Director (a civilian agency component), was executed without a set-aside designation and carried an ultimate completion date of February 28, 2013. Performance was to take place in Bethesda, Maryland 20892, indicating support for federal operations in the National Institutes of Health area.
This contract award represents a task order placed against an existing blanket purchase agreement vehicle, a procurement mechanism that allows federal agencies to efficiently access pre-negotiated products and services from qualified vendors. Pierce Biotechnology, operating under its parent company Thermo Electron Corporation—a recognized supplier of scientific instruments and analytical equipment to federal agencies—provided specialized pharmaceutical and biological materials to support the funding agency's research, medical, or regulatory initiatives. The modest contract value reflects the specific nature and quantity of materials requisitioned through this BPA call mechanism.
Quick answers
Who was awarded contract HHSN26300197?
HHSN26300197 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on May 24, 2012.
How much is contract HHSN26300197 worth?
The government has obligated $5,215 on HHSN26300197.
Is contract HHSN26300197 an order under another contract?
Yes. HHSN26300197 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300197 competed?
The extent of competition for HHSN26300197 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award